A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.
Nov 17, 2020
0
2
Cleveland Clinic researchers have found that cryoballoon ablation as the initial treatment for atrial fibrillation is more effective than current standard-of-care management using medications. The study was published today ...
Nov 17, 2020
0
7
About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, ...
Oct 29, 2020
0
6
Research at Washington State University sheds new light on one molecule that may be used to treat a heart condition that can lead to stroke, heart attack and other forms of heart disease.
Oct 27, 2020
0
9
Building on previous research 1—3 led by Joan Seoane, Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor, latest findings from a proof-of-concept study published ...
Oct 27, 2020
0
22
For the first time, researchers have directly visualized how speaking produces and expels droplets of saliva into the air. The smallest droplets can be inhaled by other people and are a primary way that respiratory infections ...
Oct 13, 2020
0
10
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study.
Oct 8, 2020
0
12
Ganoderma lucidum, known as the yeongji mushroom in Korea and reishi or lingzhi elsewhere, is considered a modern-day elixir and has long been used medicinally in China, Japan and Korea. Ganoderic acid, an active ingredient ...
Oct 7, 2020
0
1
Next-generation sequencing (NGS) of cell-free DNA (cfDNA) obtained from blood samples may improve diagnostic testing in patients with advanced NSCLC, and may also be faster and less expensive compared to standard tissue profiling, ...
Oct 2, 2020
0
1
A team led by Massimo Squatrito, Head of the Seve Ballesteros Foundation Brain Tumor Group at the Spanish National Cancer Research Centre (CNIO), has made important findings of how some gliomas can acquire chemoresistance. ...
Aug 4, 2020
0
2
